Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 5087
Country/Region: Kenya
Year: 2007
Main Partner: University of Nairobi
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $200,000

Funding for Biomedical Prevention: Injection Safety (HMIN): $200,000

1. LIST OF RELATED ACTIVITIES This activity is linked to other IS activities (#7010, #8824, #8821).

2. ACTIVITY DESCRIPTION This activity relates to the prevention of HIV transmission by medical injections through acquisition of strategic information by the generation of a sound evidence base on injection practices in a spectrum of health care facilities across the country including provincial, district and faith-based hospitals, health centers, nursing homes and dispensaries. The University of Nairobi, Clinical Epidemiology Unit (CEU) will implement this activity. CEU was established in 1989 within the College of Health Sciences, University of Nairobi, and is a member of the International Clinical Epidemiology Network (INCLEN), founded in 1980 with support from the Rockefeller Foundation.

It is comprised of a team of medical and public health specialists brought together by the common need of creating a pool of experts in health research development. Its multidisciplinary nature permits the provision of a wide range of quality services in health research, training, study design, data collection, data analysis and translation of research findings into health action through policy change and practice.

Two targeted evaluations will be conducted by the CEU to determine:

1. Injection practices, factors that influence demand for injections, prescription of injections and reuse of injection equipment in Kenya, injection use in the informal sector and the prevalence of needle stick injuries. The direct and indirect cost of injectable therapy as compared to alternative routes of medication will be determined with a view to advocating for rational injection use and review of national treatment guidelines and Essential Drugs Lists.

2. Attitudes, beliefs and practices related to the use of suppositories in Kenya. Information from this activity will guide the development of information, education and communication material targeting policy makers, health care workers and the community with the aim of changing misconceptions about injections and promoting rational injection use and safe injection practices.

3. CONTRIBUTIONS TO OVERALL PROGRAM AREA Strategic information from this activity will guide intervention programs in Injection Safety as well as all HIV/AIDS prevention and treatment and nfection prevention and control interventions in the Ministry of Health. Additionally, the strategic information will form a basis for monitoring and evaluating the success of injection safety interventions. As the HIV treatment program is scaled up and brings more HIV/AIDS patients to health care facilities, measures must be put in to place to protect health care workers and other patients from nosocomial infections. This program will contribute to the aversion of up to 5% new cases of HIV in the country.

4. LINKS TO OTHER ACTIVITIES This activity is linked to injection safety initiatives implemented by the Ministry of Health, National AIDS and STI Control Program (NASCOP) (#7010), Danya International (#8824) and JHPIEGO (#8821) and to PEPFAR care and treatment programs.

5. POPULATIONS BEING TARGETED This activity targets all health care workers, nurses, doctors, clinical officers, lab personnel, health care waste handlers, policy makers and the general public.

6. EMPHASIS AREAS This activity consists of two targeted evaluations and minor emphasis in advocacy, development and dissemination of policies, guidelines and protocols for best practice and evidence-based approaches. This activity will also contribute to local organization capacity development.